Idiopathic adult growth hormone deficiency

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 6, 2013, Pages 2187-2197

  Melmed, Shlomo ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLUCAGON; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

AGING; ARTHRALGIA; BONE MASS; CARPAL TUNNEL SYNDROME; CHEMICAL ANALYSIS; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DYSPNEA; EDEMA; FAT MASS; FATIGUE; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HEAD INJURY; HEART DISEASE; HORMONE SYNTHESIS; HUMAN; HYPOPITUITARISM; IDIOPATHIC ADULT GROWTH HORMONE DEFICIENCY; INSOMNIA; MORBIDITY; MUSCLE MASS; MYALGIA; OBESITY; PARESTHESIA; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SLEEP DISORDERED BREATHING; SWEATING; TRAFFIC ACCIDENT;

ADULT; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS;

EID: 84878491971     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-4012     Document Type: Review

References (83)

1. Salomon F, Cuneo RC, Hesp R, Sonksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med. 1989;321:1797-1803. (Pubitemid 20015573)
2. Ho KK. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol. 2007;157:695-700.
3. Hoffman AR, Kuntze JE, Baptista J, et al. Growth hormone (GH) replacement therapy in adult-onset GH deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab. 2004;89:2048-2056. (Pubitemid 38619832)
4. Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML; Endocrine Society. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96:1587-1609.
5. Webb SM, Strasburger CJ, Mo D, et al. Changing patterns of the adult growth hormone deficiency diagnosis documented in a decade-long global surveillance database. J Clin Endocrinol Metab. 2009;94:392-399.
6. Abs R, Bengtsson BA, Hernberg-Stahl E, et al. GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety. Clin Endocrinol (Oxf). 1999;50:703-713. (Pubitemid 29284503)
7. Fleetwood MR, Ho Y, Cooke NE, Liebhaber SA. DNase I hypersensitive site II of the human growth hormone locus control region mediates an essential and distinct long-range enhancer function. J Biol Chem. 2012;287:25454-25465.
8. Frohman LA, Burek L, Stachura MA. Characterization of growth hormone of different molecular weights in rat, dog and human pituitaries. Endocrinology. 1972;91:262-269.
9. Ho Y, Elefant F, Liebhaber SA, Cooke NE. Locus control region transcription plays an active role in long-range gene activation. Mol Cell. 2006;23:365-375. (Pubitemid 44128843)
10. Casanueva FF, Camina JP, Carreira MC, Pazos Y, Varga JL, Schally AV. Growth hormone-releasing hormone as an agonist of the ghrelin receptor GHS-R1a. Proc Natl Acad Sci USA. 2008;105:20452-20457.
11. Ben-Shlomo A, Melmed S. Pituitary somatostatin receptor signaling. Trends Endocrinol Metab. 2010;21:123-133.
12. Yamashita S, Melmed S. Insulinlike growth factor I regulation of growth hormone gene transcription in primary rat pituitary cells. J Clin Invest. 1987;79:449-452. (Pubitemid 17009678)
13. Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev. 1998;19:717-797. (Pubitemid 128506521)
14. Goldenberg N, Barkan A. Factors regulating growth hormone secretion in humans. Endocrinol Metab Clin North Am. 2007;36:37-55.
15. Brooks AJ, Waters MJ. The growth hormone receptor: mechanism of activation and clinical implications. Nat Rev Endocrinol. 2010;6:515-525.
16. Sotiropoulos A, Ohanna M, Kedzia C, et al. Growth hormone promotes skeletal muscle cell fusion independent of insulin-like growth factor 1 up-regulation. Proc Natl Acad Sci USA. 2006;103:7315-7320. (Pubitemid 43727830)
17. Wang J, Zhou J, Cheng CM, Kopchick JJ, Bondy CA. Evidence supporting dual, IGF-I-independent and IGF-I-dependent, roles for GH in promoting longitudinal bone growth. J Endocrinol. 2004;180:247-255. (Pubitemid 38312605)
18. Lipworth WL, Ho K, Kerridge IH, Day RO. Drug policy at the margins: the case of growth hormone replacement for adults with severe growth hormone deficiency. Med J Aust. 2012;197:204-205.
19. Olshansky SJ, Perls TT. New developments in the illegal provision of growth hormone for "anti-aging" and bodybuilding. JAMA. 2008;299:2792-2794. (Pubitemid 351846855)
20. Birzniece V, Nelson AE, Ho KK. Growth hormone and physical performance. Trends Endocrinol Metab. 2011;22:171-178.
21. Melmed S. Supplemental growth hormone in healthy adults: the endocrinologist's responsibility. Nat Clin Pract Endocrinol Metab. 2006;2:119.
22. Clemmons DR. Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. Clin Chem. 2011;57:555-559.
23. Shalet SM. Partial growth hormone deficiency in adults; should we be looking for it? Clin Endocrinol (Oxf). 2010;73:432-435.
24. Gleeson HK, Gattamaneni HR, Smethurst L, Brennan BM, Shalet SM. Reassessment of growth hormone status is required at final height in children treated with growth hormone replacement after radiation therapy. J Clin Endocrinol Metab. 2004;89:662-666. (Pubitemid 38269874)
25. Aimaretti G, Baffoni C, Bellone S, et al. Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus- arginine test. J Clin Endocrinol Metab. 2000;85:3693-3699.
26. Schneider HJ, Rovere S, Corneli G, et al. Endocrine dysfunction in patients operated on for non-pituitary intracranial tumors. Eur J Endocrinol. 2006;155:559-566. (Pubitemid 44608429)
27. Snyder PJ, Fowble BF, Schatz NJ, Savino PJ, Gennarelli TA. Hypopituitarism following radiation therapy of pituitary adenomas. Am J Med. 1986;81:457-462. (Pubitemid 16003868)
28. Benvenga S, Campenni A, Ruggeri RM, Trimarchi F. Clinical review 113: hypopituitarism secondary to head trauma. J Clin Endocrinol Metab. 2000;85:1353-1361. (Pubitemid 32289472)
29. Gasco V, Corneli G, Rovere S, et al. Diagnosis of adult GH deficiency. Pituitary. 2008;11:121-128.
30. Chanson P, Cailleux-Bounacer A, Kuhn JM, et al. Comparative validation of the growth hormone-releasing hormone and arginine test for the diagnosis of adult growth hormone deficiency using a growth hormone assay conforming to recent international recommendations. J Clin Endocrinol Metab. 2010;95:3684-3692.
31. Yuen KC, Biller BM, Molitch ME, Cook DM. Clinical review: is lack of recombinant growth hormone (GH)-releasing hormone in the United States a setback or time to consider glucagon testing for adult GH deficiency? J Clin Endocrinol Metab. 2009;94:2702-2707.
32. Biller BM, Samuels MH, Zagar A, et al. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab. 2002;87:2067-2079. (Pubitemid 34521490)
33. Popovic V, Leal A, Micic D, et al. GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults. Lancet. 2000;356:1137-1142.
34. Colao A, Di Somma C, Savastano S, et al. A reappraisal of diagnosing GH deficiency in adults: role of gender, age, waist circumference, and body mass index. J Clin Endocrinol Metab. 2009;94:4414-4422.
35. Bonert VS, Elashoff JD, Barnett P, Melmed S. Body mass index determines evoked growth hormone (GH) responsiveness in normal healthy male subjects: diagnostic caveat for adult GH deficiency. J Clin Endocrinol Metab. 2004;89:3397-3401. (Pubitemid 38951910)
36. Makimura H, Stanley T, Mun D, You SM, Grinspoon S. The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men. J Clin Endocrinol Metab. 2008;93:4254-4260. (Pubitemid 352789519)
37. Veldhuis JD, Roelfsema F, Keenan DM, Pincus S. Gender, age, body mass index, and IGF-I individually and jointly determine distinct GH dynamics: analyses in one hundred healthy adults. J Clin Endocrinol Metab. 2011;96:115-121.
38. Aimaretti G, Fanciulli G, Bellone S, et al. Enhancement of the peripheral sensitivity to growth hormone in adults with GH deficiency. Eur J Endocrinol. 2001;145:267-272. (Pubitemid 32825658)
39. Clasey JL, Weltman A, Patrie J, et al. Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors. J Clin Endocrinol Metab. 2001;86:3845-3852. (Pubitemid 32755987)
40. Thorner MO. Statement by the Growth Hormone Research Society on the GH/IGF-I axis in extending health span. J Gerontol A Biol Sci Med Sci. 2009;64:1039-1044.
41. Luque RM, Lin Q, Cordoba-Chacon J, et al. Metabolic impact of adult-onset, isolated, growth hormone deficiency (AOiGHD) due to destruction of pituitary somatotropes. PLoS One. 2011;6:e15767.
42. Hartman ML, Crowe BJ, Biller BM, Ho KK, Clemmons DR, Chipman JJ. Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? J Clin Endocrinol Metab. 2002;87:477-485. (Pubitemid 34158208)
43. Holmes SJ, Shalet SM. Characteristics of adults who wish to enter a trial of GH repacement. 1995;42:613-618.
44. Cuneo RC, Salomon F, McGauley GA, Sonksen PH. The growth hormone deficiency syndrome in adults. Clin Endocrinol (Oxf). 1992;37:387-397.
45. Brabant G, Poll EM, Jonsson P, Polydorou D, Kreitschmann-Andermahr I. Etiology, baseline characteristics, and biochemical diagnosis of GH deficiency in the adult: are there regional variations? Eur J Endocrinol. 2009;161(suppl 1):S25-S31.
46. van Nieuwpoort IC, van Bunderen CC, Arwert LI, et al. Dutch National Registry of GH Treatment in Adults: patient characteristics and diagnostic test procedures. Eur J Endocrinol. 2011;164:491-497.
47. Nystrom HF, Saveanu A, Barbosa EJ, et al. Detection of genetic hypopituitarism in an adult population of idiopathic pituitary insufficiency patients with growth hormone deficiency. Pituitary. 2011;14:208-216.
48. Bates AS, Van't Hoff W, Jones PJ, Clayton RN. The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab. 1996;81:1169-1172. (Pubitemid 26083989)
49. Bulow B, Hagmar L, Eskilsson J, Erfurth EM. High incidence of cardiovascular disease and increased prevalence of risk factors in females with hypopituitarism. In: Program of the 81st Annual Meeting of The Endocrine Society; June 12-15, 1999; San Diego, CA; Abstract OR14-13.
50. Tomlinson JW, Holden N, Hills RK, et al. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet. 2001;357:425-431.
51. Attanasio AF, Lamberts SW, Matranga AM, et al. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. J Clin Endocrinol Metab. 1997;82:82-88. (Pubitemid 27021275)
52. Klose M, Jonsson B, Abs R, et al. From isolated GH deficiency to multiple pituitary hormone deficiency: an evolving continuum - a KIMS analysis. Eur J Endocrinol. 2009;161(Suppl 1):S75-S83.
53. Murray RD, Bidlingmaier M, Strasburger CJ, Shalet SM. The diagnosis of partial growth hormone deficiency in adults with a putative insult to the hypothalamo-pituitary axis. J Clin Endocrinol Metab. 2007;92:1705-1709. (Pubitemid 46997175)
54. Lieberman SA, Oberoi AL, Gilkison CR, Masel BE, Urban RJ. Prevalence of neuroendocrine dysfunction in patients recovering from traumatic brain injury. J Clin Endocrinol Metab. 2001;86:2752-2756. (Pubitemid 32545734)
55. Schneider HJ, Aimaretti G, Kreitschmann-Andermahr I, Stalla GK, Ghigo E. Hypopituitarism. Lancet. 2007;369:1461-1470. (Pubitemid 46635784)
56. Schneider HJ, Kreitschmann-Andermahr I, Ghigo E, Stalla GK, Agha A. Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review. JAMA. 2007;298:1429-1438. (Pubitemid 47481609)
57. Tanriverdi F, Unluhizarci K, Kocyigit I, et al. Brief communication: pituitary volume and function in competing and retired male boxers. Ann Intern Med. 2008;148:827-831. (Pubitemid 351786930)
58. Gasperi M, Cecconi E, Grasso L, et al. GH secretion is impaired in patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 2002;87:1961-1964. (Pubitemid 34521474)
59. De Bellis A, Pane E, Bellastella G, et al Italian Autoimmune Hypophysitis Network Study. Detection of antipituitary and antihypothalamus antibodies to investigate the role of pituitary or hypothalamic autoimmunity in patients with selective idiopathic hypopituitarism. Clin Endocrinol (Oxf). 2011;75:361-366.
60. Bellastella G, Rotondi M, Pane E, et al Italian Autoimmune Hypophysitis Network Study. Predictive role of the immunostaining pattern of immunofluorescence and the titers of antipituitary antibodies at presentation for the occurrence of autoimmune hypopituitarism in patients with autoimmune polyendocrine syndromes over a five-year follow-up. J Clin Endocrinol Metab. 2010;95:3750-3757.
61. Yamamoto M, Iguchi G, Takeno R, et al. Adult combined GH, prolactin, and TSH deficiency associated with circulating PIT-1 antibody in humans. J Clin Invest. 2011;121:113-119.
62. Gasperi M, Aimaretti G, Cecconi E, et al. Impairment of GH secretion in adults with primary empty sella. J Endocrinol Invest. 2002;25:329-333. (Pubitemid 34436127)
63. Arafah BM, Prunty D, Ybarra J, Hlavin ML, Selman WR. The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas. J Clin Endocrinol Metab. 2000;85:1789-1793. (Pubitemid 32269277)
64. Alatzoglou KS, Dattani MT. Genetic causes and treatment of isolated growth hormone deficiency - an update. Nat Rev Endocrinol. 2010;6:562-576.
65. Melmed S. Mechanisms for pituitary tumorigenesis: the plastic pituitary. J Clin Invest. 2003;112:1603-1618. (Pubitemid 38063716)
66. Gotherstrom G, Elbornsson M, Stibrant-Sunnerhagen K, Bengtsson BA, Johannsson G, Svensson J. Ten years of growth hormone (GH) replacement normalizes muscle strength in GH-deficient adults. J Clin Endocrinol Metab. 2009;94:809-816.
67. Rosilio M, Blum WF, Edwards DJ, et al. Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism (QLS-H). J Clin Endocrinol Metab. 2004;89:1684-1693. (Pubitemid 38514701)
68. Holt RI, Erotokritou-Mulligan I, Sonksen PH. The history of doping and growth hormone abuse in sport. Growth Horm IGF Res. 2009;19:320-326.
69. Giannoulis MG, Sonksen PH, Umpleby M, et al. The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial. J Clin Endocrinol Metab. 2006;91:477-484. (Pubitemid 43236912)
70. Graham MR, Baker JS, Evans P, et al. Physical effects of short-term recombinant human growth hormone administration in abstinent steroid dependency. Horm Res. 2008;69:343-354. (Pubitemid 351809498)
71. Meinhardt U, Nelson AE, Hansen JL, et al. The effects of growth hormone on body composition and physical performance in recreational athletes: a randomized trial. Ann Intern Med. 2010;152:568-577.
72. Melmed S. Acromegaly pathogenesis and treatment. J Clin Invest. 2009;119:3189-3202.
73. Karges B, Pfaffle R, Boehm BO, Karges W. Acromegaly induced by growth hormone replacement therapy. Horm Res. 2004;61:165-169. (Pubitemid 38437685)
74. Liu H, Bravata DM, Olkin I, et al. Systematic review: the effects of growth hormone on athletic performance. Ann Intern Med. 2008;148:747-758. (Pubitemid 351717421)
75. Chipman JJ, Attanasio AF, Birkett MA, Bates PC, Webb S, Lamberts SW. The safety profile of GH replacement therapy in adults. Clin Endocrinol (Oxf). 1997;46:473-481. (Pubitemid 27242684)
76. Hartman ML, Xu R, Crowe BJ, et al; International HypoCCS Advisory Board. 2013 Prospective safety surveillance of GH-deficient adults: comparison of GH-treated vs untreated patients. J Clin Endocrinol Metab. 2013;98:980-988.
77. Attanasio AF, Jung H, Mo D, et al; HypoCCS International Advisory Board. Prevalence and incidence of diabetes mellitus in adult patients on growth hormone replacement for growth hormone deficiency: a surveillance database analysis. J Clin Endocrinol Metab. 2011;96:2255-2261.
78. Monson JP. Long-term experience with GH replacement therapy: efficacy and safety. Eur J Endocrinol. 2003;148(suppl 2):S9-S14. (Pubitemid 36531482)
79. Young J, Anwar A. Strong diabetes. Br J Sports Med 2007;41:335-336; discussion 336.
80. Cittadini A, Berggren A, Longobardi S, et al. Supraphysiological doses of GH induce rapid changes in cardiac morphology and function. J Clin Endocrinol Metab. 2002;87:1654-1659. (Pubitemid 34618502)
81. Melmed S. Medical progress: acromegaly. N Engl J Med. 2006;355:2558-2573.
82. Littley MD, Shalet SM, Beardwell CG, Ahmed SR, Applegate G, Sutton ML. Hypopituitarism following external radiotherapy for pituitary tumours in adults. Q J Med. 1989;70:145-160. (Pubitemid 19115954)
83. Melmed S, Ho K. Pituitary physiology and diagnostic evaluation. In: Melmed S, Polonsky KS, Reed Larsen P, Kronenberg HM, eds. Williams textbook of endocrinology, 12th ed. Philadelphia, PA: Elsevier; 2010.